ICU Medical, Inc. (NASDAQ:ICUI) Chairman Vivek Jain sold 97,795 shares of the firm’s stock in a transaction on Friday, October 20th. The shares were sold at an average price of $190.00, for a total transaction of $18,581,050.00. Following the completion of the transaction, the chairman now directly owns 67,680 shares of the company’s stock, valued at $12,859,200. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Vivek Jain also recently made the following trade(s):

  • On Monday, October 9th, Vivek Jain sold 2,200 shares of ICU Medical stock. The stock was sold at an average price of $190.91, for a total transaction of $420,002.00.
  • On Tuesday, October 10th, Vivek Jain sold 2,205 shares of ICU Medical stock. The stock was sold at an average price of $190.91, for a total transaction of $420,956.55.

ICU Medical, Inc. (ICUI) traded up 0.97% during trading on Monday, reaching $193.20. 61,741 shares of the company’s stock were exchanged. The firm’s 50-day moving average price is $184.45 and its 200-day moving average price is $169.81. The firm has a market cap of $3.83 billion, a price-to-earnings ratio of 77.37 and a beta of 0.35. ICU Medical, Inc. has a 12 month low of $127.00 and a 12 month high of $195.20.

ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.52 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.58 by ($0.06). The firm had revenue of $331.51 million for the quarter, compared to analysts’ expectations of $318.30 million. ICU Medical had a net margin of 6.10% and a return on equity of 7.56%. The business’s quarterly revenue was up 242.8% on a year-over-year basis. During the same period in the prior year, the business posted $1.15 earnings per share. On average, equities research analysts anticipate that ICU Medical, Inc. will post $4.11 EPS for the current year.

ILLEGAL ACTIVITY WARNING: “ICU Medical, Inc. (ICUI) Chairman Vivek Jain Sells 97,795 Shares” was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2017/10/23/icu-medical-inc-icui-chairman-vivek-jain-sells-97795-shares.html.

A number of equities analysts have commented on the stock. Zacks Investment Research raised shares of ICU Medical from a “sell” rating to a “hold” rating in a research report on Wednesday, October 11th. KeyCorp assumed coverage on shares of ICU Medical in a research report on Tuesday, October 17th. They set a “sector weight” rating for the company. BidaskClub cut shares of ICU Medical from a “hold” rating to a “sell” rating in a research report on Wednesday, August 9th. Finally, Gabelli reaffirmed a “buy” rating on shares of ICU Medical in a research report on Friday, August 11th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average target price of $193.00.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of ICU Medical by 10.3% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 707 shares of the medical instruments supplier’s stock valued at $122,000 after buying an additional 66 shares in the last quarter. Riverhead Capital Management LLC raised its holdings in shares of ICU Medical by 99.8% during the 2nd quarter. Riverhead Capital Management LLC now owns 999 shares of the medical instruments supplier’s stock valued at $172,000 after buying an additional 499 shares in the last quarter. Victory Capital Management Inc. raised its holdings in shares of ICU Medical by 17.6% during the 2nd quarter. Victory Capital Management Inc. now owns 1,050 shares of the medical instruments supplier’s stock valued at $181,000 after buying an additional 157 shares in the last quarter. Parametrica Management Ltd purchased a new position in shares of ICU Medical during the 2nd quarter valued at about $213,000. Finally, Teacher Retirement System of Texas purchased a new position in shares of ICU Medical during the 2nd quarter valued at about $214,000. 78.13% of the stock is currently owned by institutional investors.

ICU Medical Company Profile

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Insider Buying and Selling by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.